Principal Stratification in Causal Inference

DOI10.1111/j.0006-341X.2002.00021.xzbMath1209.62288WikidataQ34065063 ScholiaQ34065063MaRDI QIDQ3078899

Donald B. Rubin, C. E. Frangakis

Publication date: 1 March 2011

Published in: Biometrics (Search for Journal in Brave)

zbMATH Keywords

missing data; causal inference; quality of life; principal stratification; surrogate; Rubin causal model; biomarker; censoring by death; posttreatment variable

Mathematics Subject Classification ID

62P10: Applications of statistics to biology and medical sciences; meta analysis

62N01: Censored data models

Related Items

A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint, Direct and Indirect Causal Effects via Potential Outcomes*, Instrumental Variable Estimators for Binary Outcomes, Bayesian Inference for the Causal Effect of Mediation, Compliance Mixture Modelling with a Zero‐Effect Complier Class and Missing Data, Partially Hidden Markov Model for Time-Varying Principal Stratification in HIV Prevention Trials, Bayesian Inference for Dynamic Treatment Regimes: Mobility, Equity, and Efficiency in Student Tracking, Evaluating the Effect of Training on Wages in the Presence of Noncompliance, Nonemployment, and Missing Outcome Data, Does Marriage Boost Men’s Wages?: Identification of Treatment Effects in Fixed Effects Regression Models for Panel Data, Augmented Designs to Assess Immune Response in Vaccine Trials, In Praise of Simplicity not Mathematistry! Ten Simple Powerful Ideas for the Statistical Scientist, Uses and limitations of randomization-based efficacy estimators, Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis, Structural mean models for compliance analysis in randomized clinical trials and the impact of errors on measures of exposure, Designs in partially controlled studies: messages from a review, Causal Mediation Analyses with Rank Preserving Models, Uses and limitations of randomization-based efficacy estimators, Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis, Structural mean models for compliance analysis in randomized clinical trials and the impact of errors on measures of exposure, Designs in partially controlled studies: messages from a review, Application of the Principal Stratification Approach to the Faenza Randomized Experiment on Breast Self‐Examination, Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials, Polydesigns and Causal Inference, A Potential Outcomes Approach to Developmental Toxicity Analyses, Rejoinder, Rejoinder, Likelihood Methods for Treatment Noncompliance and Subsequent Nonresponse in Randomized Trials, Estimating Percentile-Specific Treatment Effects in Counterfactual Models: A Case-Study of Micronutrient Supplementation, Birth Weight and Infant Mortality, Discussion on “Surrogate Measures and Consistent Surrogates”, Discussion on “Surrogate Measures and Consistent Surrogates”, Assessing Vaccine Effects in Repeated Low‐Dose Challenge Experiments, BPrinStratTTE, Chop-Lump Tests for Vaccine Trials, Bounds on the complier average causal effect in randomized trials with noncompliance, A note on bounds for the causal infectiousness effect in vaccine trials, Causal inference through potential outcomes and principal stratification: application to studies with ``censoring due to death, Defining and estimating intervention effects for groups that will develop an auxiliary outcome, On instrumental variables estimation of causal odds ratios, The potential for bias in principal causal effect estimation when treatment received depends on a key covariate, A causal framework for surrogate endpoints with semi-competing risks data, Conceptual, computational and inferential benefits of the missing data perspective in applied and theoretical statistical problems, Simple relations between principal stratification and direct and indirect effects, For objective causal inference, design trumps analysis, An application of principal stratification to control for institutionalization at follow-up in studies of substance abuse treatment programs, Estimating the principal stratum direct effect when the total effects are consistent between two standard populations, Causal inference in statistics: an overview, Identifiability of causal effects on a binary outcome within principal strata, Exploiting multiple outcomes in Bayesian principal stratification analysis with application to the evaluation of a job training program, Sharp bounds on the causal effects in randomized experiments with ``truncation-by-death, A note on endogenous control variables in causal studies, Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model, Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials, Sensitivity Analysis of Per-Protocol Time-to-Event Treatment Efficacy in Randomized Clinical Trials, Using Secondary Outcomes to Sharpen Inference in Randomized Experiments With Noncompliance, Surrogate Measures and Consistent Surrogates, Marginal structural models for estimating principal stratum direct effects under the monotonicity assumption, Comparing Biomarkers as Principal Surrogate Endpoints, Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time, Evaluating Correlation-Based Metric for Surrogate Marker Qualification within a Causal Correlation Framework, Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine Trials, Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials, Sensitivity Analyses Comparing Time-to-Event Outcomes Only Existing in a Subset Selected Postrandomization and Relaxing Monotonicity, Augmented Designs to Assess Principal Strata Direct Effects, Estimation of Causal Effects in Latent Strata with an Encouragement for Response, Multiple-Bias Modelling for Analysis of Observational Data, Bounds on Causal Effects in Three-Arm Trials With Non-Compliance, An Extended General Location Model for Causal Inferences from Data Subject to Noncompliance and Missing Values, Applications of a Parametric Model for Informative Censoring, Evaluating Candidate Principal Surrogate Endpoints, A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials, Efficacy studies of malaria treatments in Africa: efficient estimation with missing indicators of failure, Simple and Globally Convergent Methods for Accelerating the Convergence of Any EM Algorithm, Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials, Nested Markov Compliance Class Model in the Presence of Time‐Varying Noncompliance, Sensitivity Analysis for Principal Stratum Direct Effects, with an Application to a Study of Physical Activity and Coronary Heart Disease, On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm, Related Causal Frameworks for Surrogate Outcomes, A Comparison of Methods for Estimating the Causal Effect of a Treatment in Randomized Clinical Trials Subject to Noncompliance

Cites Work

• Bayesian inference for causal effects in randomized experiments with noncompliance
• Bayesian inference for causal effects: The role of randomization
• Addressing an Idiosyncrasy in Estimating Survival Curves Using Double Sampling in the Presence of Self-Selected Right Censoring
• Identification of Causal Effects Using Instrumental Variables
• The central role of the propensity score in observational studies for causal effects
• Statistics and Causal Inference
• Dummy Endogenous Variables in a Simultaneous Equation System
• Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes
• Regression Analysis of Grouped Survival Data: Informative Censoring and Double Sampling
• Adjusting for Differential Rates of Prophylaxis Therapy for PCP in High-Versus Low-Dose AZT Treatment Arms in an AIDS Randomized Trial
• Causal Inference in a Placebo-Controlled Clinical Trial With Binary Outcome and Ordered Compliance
• Bounds on Treatment Effects From Studies With Imperfect Compliance
• The validation of surrogate endpoints in meta-analyses of randomized experiments
• Assessing the effect of an influenza vaccine in an encouragement design
• On meta-analytic assessment of surrogate outcomes
• Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models
• Causal Inference Without Counterfactuals
• Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
• A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
• Clustered Encouragement Designs with Individual Noncompliance: Bayesian Inference with Randomization, and Application to Advance Directive Forms